<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-13T01:22:37Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:10459.1/48452" metadataPrefix="oai_dc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:10459.1/48452</identifier><datestamp>2024-12-05T21:23:13Z</datestamp><setSpec>com_2072_3622</setSpec><setSpec>col_2072_479130</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Dyslipidaemia in HIV-infected women on antiretroviral therapy. Analysis of 922 patients from the Spanish VACH cohort</dc:title>
   <dc:creator>Estrada, Vicente</dc:creator>
   <dc:creator>Geijo, Paloma</dc:creator>
   <dc:creator>Fuentes Ferrer, Manuel</dc:creator>
   <dc:creator>García Alcalde, María Luisa</dc:creator>
   <dc:creator>Rodrigo, María</dc:creator>
   <dc:creator>Galindo, María José</dc:creator>
   <dc:creator>Muñoz, Agustín</dc:creator>
   <dc:creator>Domingo, Pere</dc:creator>
   <dc:creator>Ribera, Esteve</dc:creator>
   <dc:creator>Cosín, Jaime</dc:creator>
   <dc:creator>Viciana, Pompeyo</dc:creator>
   <dc:creator>Lozano, Fernando</dc:creator>
   <dc:creator>Terrón, Alberto</dc:creator>
   <dc:creator>Vergara, Antonio</dc:creator>
   <dc:creator>Teira, Ramón</dc:creator>
   <dc:creator>Muñoz Sánchez, Josefa</dc:creator>
   <dc:creator>Roca, Bernardino</dc:creator>
   <dc:creator>Sánchez, Trinitario</dc:creator>
   <dc:creator>López Aldeguer, José</dc:creator>
   <dc:creator>Deig, Elisabeth</dc:creator>
   <dc:creator>Vidal, Francisco</dc:creator>
   <dc:creator>Pedrol, Enric</dc:creator>
   <dc:creator>Castaño Carracedo, Manuel</dc:creator>
   <dc:creator>Puig, Teresa</dc:creator>
   <dc:creator>Garrido, Myriam</dc:creator>
   <dc:creator>Suárez Lozano, Ignacio</dc:creator>
   <dc:description>Background: Information concerning lipid disturbances in HIV-infected women on antiretroviral therapy (ART) is scarce. The objective of the study is to describe the lipid profile in a large cohort of HIV-infected women on contemporary ART and analyse differences between regimes and patient's characteristics.&#xd;
Methods: Observational, multicentre, cross-sectional study from the Spanish VACH Cohort. 922 women on stable ART without lipid-lowering treatment were included.&#xd;
Results: Median age was 42 years, median CD4 lymphocyte count was 544 cells/mm3, and 85.6% presented undetectable HIV-1 viral load. Median total cholesterol (TC) was 189 mg/dL (interquartile range, IQR, 165-221), HDL cholesterol 53 mg/dL (IQR, 44-64), LDL cholesterol 108 mg/dL (IQR, 86-134), and triglycerides 116 mg/dL (IQR, 85-163). Mean accumulated time on ART was 116 months; 47.4% were on NNRTI-based regimes, 44.7% on PI, and 6.7% on only-NRTI therapy. 43.8% were also hepatitis C (HCV) coinfected. Patients on PI treatment presented higher TC/HDL ratio than those on NNRTI (p &lt; 0.001). Significantly higher HDL values were observed in NNRTI-treated patients. HCV-coinfected patients presented lower TC/HDL ratio than the non HCV-coinfected. In multivariate analysis, factors independently associated with TC/HDL ratio were age, triglyceride levels and HCV co-infection. PI treatment presented a non-significant association with higher TC/HDL ratio.&#xd;
Conclusions: In HIV-infected women, the NNRTI-based ART is associated with a better lipid profile than the PI-based. Factors unrelated to ART selection may also exert an independent, significant influence on lipids; in particular, age, and triglyceride levels are associated with an increased TC/HDL ratio while HCV co-infection is associated with a reduced TC/HDL ratio.</dc:description>
   <dc:date>2015-07-09T10:04:13Z</dc:date>
   <dc:date>2015-07-09T10:04:13Z</dc:date>
   <dc:date>2011</dc:date>
   <dc:type>article</dc:type>
   <dc:type>publishedVersion</dc:type>
   <dc:identifier>https://doi.org/10.1186/1472-6874-11-36</dc:identifier>
   <dc:identifier>1472-6874</dc:identifier>
   <dc:identifier>http://hdl.handle.net/10459.1/48452</dc:identifier>
   <dc:identifier>http://hdl.handle.net/10459.1/48452</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>Reproducció del document publicat a https://doi.org/10.1186/1472-6874-11-36</dc:relation>
   <dc:relation>BMC Women’s Health, 2011, vol. 11, núm. 36, p. 1-8</dc:relation>
   <dc:rights>cc-by, (c) Estrada et al., 2011</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by/3.0/es/</dc:rights>
   <dc:publisher>BioMed Central</dc:publisher>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>